American Oriental Bioengineering, Inc.
AOBI · OTC
12/31/2012 | 12/31/2011 | 12/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Market Cap | $14,554 | $10,491 | $44,886 | $86,737 |
| - Cash | $7,097 | $52,628 | $94,569 | $91,126 |
| + Debt | $67,643 | $116,440 | $123,236 | $129,581 |
| Enterprise Value | $75,100 | $74,303 | $73,553 | $125,191 |
| Revenue | $145,100 | $212,690 | $305,944 | $296,151 |
| % Growth | -31.8% | -30.5% | 3.3% | – |
| Gross Profit | $44,358 | $99,751 | $157,758 | $166,783 |
| % Margin | 30.6% | 46.9% | 51.6% | 56.3% |
| EBITDA | -$39,637 | -$48,777 | $41,999 | $72,705 |
| % Margin | -27.3% | -22.9% | 13.7% | 24.5% |
| Net Income | -$59,713 | -$68,491 | $14,087 | $41,421 |
| % Margin | -41.2% | -32.2% | 4.6% | 14% |
| EPS Diluted | -781.24 | -901.8 | 185.37 | 1,062.12 |
| % Growth | 13.4% | -586.5% | -82.5% | – |
| Operating Cash Flow | -$46,453 | $29,956 | $8,033 | $25,409 |
| Capital Expenditures | -$26,143 | -$49,874 | -$6,082 | -$5,099 |
| Free Cash Flow | -$72,596 | -$19,918 | $1,952 | $20,310 |